Dr. Carolin Bier is a Global Medical Affairs Manager at Roche Diagnostics Solutions and is based out of Rotkreuz, Switzerland. Carolin holds a Diploma in Biochemistry from the Eberhard Karls University of Tübingen, Germany, a Doctorate in Pharmaceutical Biology and Biochemistry from the Johann-Wolfgang Goethe University of Frankfurt a.M., Germany and trained as a Postdoctoral Fellow investigating leukaemia and head and neck squamous cell carcinoma at the University Hospital of Mainz, Germany. Throughout her Roche career, Carolin worked in the Global PCR Assay Development team where she was a team leader responsible for the development of multiple tests on the cobas R 6800/8800 Systems, including cobas R SARS-CoV-2, microbiology and STI applications, as well as the tests related to transplant monitoring. After 10 exciting years in Development, Carolin joined the Global Medical Affairs Infection and Immunity Team in early 2022. In this role Carolin oversees the global medical strategy for GenMark testing solutions, which includes educating clinical laboratories on test design and clinical utility and maximising the impact of multiplex syndromic assays on medical practice.